3
4
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T62356 | Mardepodect hydrochloride | PF-2545920 HCl,Mardepodect HCl,MP-10 HCl,PF-02545920 HCl | Apoptosis , PDE |
Mardepodect hydrochloride (Mardepodect HCl) is an orally active, selective and potent inhibitor of PDE10A that crosses the blood-brain barrier (IC50: 0.37 nM).Mardepodect hydrochloride up-regulates the expression of prot... | |||
T16499 | Mardepodect | PF-2545920 | PDE |
Mardepodect (PF-2545920) is a phosphodiesterase inhibitor selective for the PDE10A subtype with an IC50 of 0.37 nM, >1000-fold selectivity over PDE. It is potentially useful for the treatment of schizophrenia. Phosphodie... | |||
T6042 | [11C]MP 10 | Mardepodect,PF-2545920 | PDE |
[11C]MP 10 (PF-2545920), a specific and effective PDE10A inhibitor (IC50=0.37 nM), is with more than1000-fold specificity activity over the PDE. |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-01751 | DR3/TNFRSF25 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
DR3/TNFRSF25 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 45.9 kDa and the accession number is Q93038-10. | |||
TMPY-02300 | BIN1 Protein, Human, Recombinant (His) | Human | E. coli |
Amphiphysin 2, also named bridging integrator-1 (BIN1) or SH3P9, Amphiphysin2/BIN1 is a crescent-shaped N-BAR protein playing a key role in forming deeply invaginated tubes in muscle T-tubules, has been recently implicat... | |||
TMPY-05760 | DR3/TNFRSF25 Protein, Human, Recombinant (hFc), Biotinylated | Human | HEK293 Cells |
DR3/TNFRSF25 Protein, Human, Recombinant (hFc), Biotinylated is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 45.9 kDa and the accession number is Q93038-10. | |||
TMPY-00961 | ADAM15 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
ADAM15 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 54 kDa and the accession number is Q13444-10. |